Cooper Companies (COO) Cash from Financing Activities (2009 - 2026)
Cooper Companies (COO) recorded quarterly Cash from Financing Activities of -$75.8 million in Q2 2026, up 48.75% quarter-over-quarter from -$147.9 million in Q1 2026, and down 781.4% year-on-year from $11.1 million in Q2 2025.
Cooper Companies (COO) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Cooper Companies has disclosed Cash from Financing Activities across 18 years of filings, most recently posting -$75.8 million for Q2 2026.
- For the quarter ending Q2 2026, Cash from Financing Activities fell 781.4% year-over-year to -$75.8 million; the trailing twelve-month figure through Apr 2026 stood at -$544.4 million (down 146.11% YoY), and the FY2025 full-year result was -$425.9 million, down 1186.48% from the prior year.
- Cash from Financing Activities was -$75.8 million for Q2 2026 at Cooper Companies, up from -$147.9 million in the prior quarter.
- Over five years, Cash from Financing Activities peaked at $1.7 billion in Q1 2022 and troughed at -$368.7 million in Q3 2022.
- The 5-year median for Cash from Financing Activities is -$66.4 million (2024), against an average of $22.7 million.
- The sharpest annual moves came in 2022 and 2023: Cash from Financing Activities soared 12552.94% in 2022, then tumbled 1713.79% in 2023.
- Year by year, Cash from Financing Activities stood at -$134.1 million in 2022, then jumped by 95.15% to -$6.5 million in 2023, then tumbled by 336.92% to -$28.4 million in 2024, then plunged by 478.87% to -$164.4 million in 2025, then soared by 53.89% to -$75.8 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$75.8 million in Q2 2026, -$147.9 million in Q1 2026, and -$164.4 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -1.35 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -414.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -13.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -255.24 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -308.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -50.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -48.13 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 Mn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | -230.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -75.80 Mn |
| Apr 30, 2026 | -75.80 Mn |
| Jan 31, 2026 | -147.90 Mn |
| Jan 31, 2026 | -147.90 Mn |
| Oct 31, 2025 | -164.40 Mn |
| Oct 31, 2025 | -164.40 Mn |
| Jul 31, 2025 | -156.30 Mn |
| Jul 31, 2025 | -156.30 Mn |
| Apr 30, 2025 | -8.60 Mn |
| Apr 30, 2025 | -8.60 Mn |
| Jan 31, 2025 | -96.60 Mn |
| Jan 31, 2025 | -96.60 Mn |
| Oct 31, 2024 | -28.40 Mn |
| Oct 31, 2024 | -28.40 Mn |
| Jul 31, 2024 | -87.60 Mn |
| Jul 31, 2024 | -87.60 Mn |
| Apr 30, 2024 | -57.10 Mn |
| Apr 30, 2024 | -57.10 Mn |
| Jan 31, 2024 | 212.30 Mn |
| Jan 31, 2024 | 212.30 Mn |